Wealthy, industrialized countries of the developed world successfully underwent the “epidemiologic transition “ from infectious diseases to degenerative diseases, but developing countries have not yet achieved that transition. This article reviews the current status of Omran's Theory of Epidemiologic Transition, comparing the burden of infectious diseases in the developed world versus the developing world. The advent of modern sanitation and hygiene practices, effective vaccines, and antibiotics have significantly diminished the burden in the developed world, but infectious diseases remain the most common cause of death worldwide. The persistence of this disease burden has been due to a failure to employee effective strategies and to unforeseen developments, such as the emergence of HIV and the re-emergence of malaria and tuberculosis driven by newly developed drug resistance. The challenge in accurately assessing infectious disease burden and developing effective interventions is reviewed along with the most common diseases and current intervention strategies.
ArmstrongG.L., ConnL.A., and PinnerR.W. (1999) Trends in infectious disease mortality in the United States during the 20th century. JAMA, 281, 61–66.
2.
TaylorR., LewisM., and PowlesJ. (1998) The Australian mortality decline: all-cause mortality 1788–1990. Aust. N.Z. J. Public Hlth., 22, 27–36.
3.
Wolleswinkel-van den BoschJ.H., LoomanC.W., Van PoppelF.W., and MackenbachJ.P. (1997) Cause-specific mortality trends in The Netherlands, 1875–1992: a formal analysis of the epidemiologic transition. Int. J. Epidemiol., 26, 772–781.
4.
De FloraS., QuagliaA., BennicelliC., and VercelliM. (2005) The epidemiological revolution of the 20th century. Faseb. J., 19, 892–897.
SassettiC.M., and RubinE.J. (2007) The open book of infectious diseases. Nat. Med., 13, 279–280.
7.
MorensD.M., FolkersG.K., and FauciA.S. (2004) The challenge of emerging and re-emerging infectious diseases. Nature, 430, 242–249.
8.
WHO. (2002) Reducing Risks, Promoting Healthy Life. World Health Report.
9.
MathersC.D., and LoncarD. (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med., 3, e442.
10.
PinnerR.W., TeutschS.M., SimonsenL., KlugL.A., GraberJ.M., ClarkeM.J., and BerkelmanR.L. (1996). Trends in infectious diseases mortality in the United States. JAMA, 275, 189–193.
11.
OmranA.R. (1971) The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem. Fund Q., 49, 509–538.
12.
Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006–2015. (2006) MMWR Morb Mortal. Wkly. Rep., 55, 511–515.
FauciA.S. (2005) Emerging and reemerging infectious diseases: the perpetual challenge. Acad. Med., 80, 1079–1085.
15.
LashleyF.R. (2006) Emerging infectious diseases at the beginning of the 21st century. Online J. Issues Nurs., 11, 2.
16.
FauciA.S. (2006) Emerging and re-emerging infectious diseases: influenza as a prototype of the host-pathogen balancing act. Cell., 124, 665–670.
17.
WalenskyR.P., PaltielA.D., LosinaE., MercincavageL.M., SchackmanB.R., SaxP.E., WeinsteinM.C., and FreedbergK.A. (2006) The survival benefits of AIDS treatment in the United States. J. Infect. Dis., 194, 11–19. Epub. 2006 Jun 1.
18.
SmitC., GeskusR., UitenbroekD., MulderD., Van Den HoekA., CoutinhoR.A., and PrinsM. (2004) Declining AIDS mortality in Amsterdam: contributions of declining HIV incidence and effective therapy. Epidemiology, 15, 536–542.
19.
DorlingD., ShawM., and Davey SmithG. (2006) Global inequality of life expectancy due to AIDS. BMJ, 332, 662–664.
20.
FischerT.K., ViboudC., ParasharU., MalekM., SteinerC., GlassR., and SimonsenL. (2007) Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993–2003. J. Infect. Dis., 195, 1117–1125. Epub. 2007 Mar 6.
21.
Soriano-GabarroM., MrukowiczJ., VesikariT., and VerstraetenT. (2006) Burden of rotavirus disease in European Union countries. Pediatr. Infect. Dis. J., 25, S7–S11.
22.
StebbinsS. (2007) Rotavirus: Disease and vaccine update, 2007. J. Fam. Pract., 56, S6–S11.
23.
GlassR.I., BreseeJ.S., TurciosR., FischerT.K., ParasharU.D., and SteeleA.D. (2005) Rotavirus vaccines: targeting the developing world. J. Infect. Dis., 192 Suppl. 1, S160–166.
24.
AgostiJ.M., and GoldieS.J. (2007) Introducing HPV vaccine in developing countries-key challenges and issues. N. Engl. J. Med., 356, 1908–1910.
25.
KaneM.A., SherrisJ., CoursagetP., AguadoT., and CuttsF. (2006) Chapter 15: HPV vaccine use in the developing world. Vaccine, 24 Suppl. 3, S132–139.
26.
TwomblyR. (2006) U.S. girls to receive HPV vaccine but picture unclear on potential worldwide use, acceptance. J. Natl. Cancer Inst., 98, 1030–1032.
27.
WittetS. (2000) Introducing GAVI and the Global Fund for Children's Vaccines. Vaccine, 19, 385–386.
28.
WalgateR. (2002) Global Fund for AIDS, TB and malaria opens shop. Bull. World Health Organ., 80, 259.
29.
PEPFAR and the fight against HIV/AIDS. (2007) lancet, 369, 1141.
30.
DragerS., GedikG., and Dal PozM.R. (2006) Health workforce issues and the Global Fund to fight AIDS, Tuberculosis and Malaria: an analytical review. Hum. Resour Health, 4, 23.
31.
NossalG.J. (2003) Gates, GAVI, the glorious global funds and more: all you ever wanted to know. Immunol. Cell. Biol., 81, 20–22.
32.
Control of infectious diseases. (1999) MMWR Morb. Mortal. Wkly. Rep., 48, 621–9.
33.
CutlerD., and MillerG. (2005) The role of public health improvements in health advances: the twentieth-century United States. Demography, 42, 1–22.
PlaneD.A., HenrieC.J., and PerryM.J. (2005) Migration up and down the urban hierarchy and across the life course. Proc. Natl. Acad. Sci. U.S.A., 102, 15313–15318. Epub. 2005 Oct. 17.
36.
BudnikA., and LiczbinskaG. (2006) Urban and rural differences in mortality and causes of death in historical Poland. Am. J. Phys. Anthropol., 129, 294–304.
37.
FreudenbergN., GaleaS., and VlahovD. (2005) Beyond urban penalty and urban sprawl: back to living conditions as the focus of urban health. J. Community Health, 30, 1–11.
38.
VlahovD., GaleaS., GibbleE., and FreudenbergN. (2005) Perspectives on urban conditions and population health. Cad. Saude Publica., 21, 949–957. Epub. 2005 May 2.
39.
VlahovD., GibbleE., FreudenbergN., and GaleaS. (2004) Cities and health: history, approaches, and key questions. Acad. Med., 79, 1133–1138.
40.
SternA.M., and MarkelH. (2004) International efforts to control infectious diseases, 1851 to the present. JAMA, 292, 1474–1479.
WilcoxL.S. (2005) Health education from 1775 to 2005. Prev. Chronic. Dis., 2 Spec no, A01. Epub. 2005 Nov. 1.
43.
ChristmasW.A., and DormanJ.M. (1996) The Storey of college health hygiene. Thomas A. Storey, MD (1875–1943) and the promotion of hygiene. J. Am. Coll. Health, 45, 27–34.
44.
StrasserS. (1996) Next to Godliness. [Review of: Hoy, S. Chasing dirt: the American pursuit of cleanliness. Oxford University Press, 1995; Williams, M. T. Washing “the great unwashed”: public baths in urban America, 1840–1920. Ohio State University Press, 1991]. Rev. Am. Hist., 24, 461–5.
45.
PollardA.J. (2007) Childhood immunisation: what is the future?Arch. Dis. Child., 92, 426–433.
46.
TengsT.O., AdamsM.E., PliskinJ.S., SafranD.G., SiegelJ.E., WeinsteinM.C., and GrahamJ.D. (1995) Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal., 15, 369–390.
47.
VallinJ., and MesleF. (2004) Convergences and divergences in mortality. A new approach to health transition. Demographic Research, accessed April 7th, 2007 at http://www.demographic-research.org2, 12–44.
48.
OlshanskyS.J., and AultA.B. (1986) The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q, 64, 355–391.
49.
FrenkJ., BobadillaJ.L., SternC., FrejkaT., and LozanoR. (1991) Elements for a theory of the health transition. Health Transit. Rev., 1, 21–38.
50.
CaselliG. (1995) The key phases of the European health transition. Pol. Popul. Rev., 73–102.
51.
GurvenM., KaplanH., and SupaA.Z. (2007) Mortality experience of Tsimane Amerindians of Bolivia: Regional variation and temporal trends. Am. J. Hum. Biol., 19, 376–398.
52.
HillK., VapattanawongP., PrasartkulP., PorapakkhamY., LimS.S., and LopezA.D. (2006) Epidemiologic transition interrupted: a reassessment of mortality trends in Thailand, 1980–2000. Int. J. Epidemiol., 36, 374–384. Epub. 2006 Dec. 20.
53.
Castillo-SalgadoC., MujicaO., and LoyolaE. (1999) A subregional assessment of demographic and health trends in the Americas: 1980–1998. Stat. Bull. Metrop. Insur Co., 80, 2–12.
54.
SerowW.J., CowartM.E., and CamezonJ. (1998) Epidemiologic transition theory and aging: Hispanic populations of North America and the Caribbean. J. Health Hum. Serv. Adm., 20, 333–347.
55.
HillK., BarkerB., and VosT. (2007) Excess Indigenous mortality: are Indigenous Australians more severely disadvantaged than other Indigenous populations?Int. J. Epidemiol., ?????
56.
HetzelD.M. (2001) Death, disease and diversity in Australia, 1951 to 2000. Med. J. Aust., 174, 21–24.
57.
RychtarikovaJ., VallinJ., and MesleF. (1989) Comparative study of mortality trends in France and the Czech Republic since 1950. Popul., 44, 291–321.
58.
ShkolnikovV.M., AndreevE.M., AnsonJ., and MesleF. (2004) The peculiar pattern of mortality of Jews in Moscow, 1993–95. Popul. Stud. (Camb)., 58, 311–329.
VallinJ. (2007) Commentary: ‘Epidemiologic transition’ interrupted or sweep to the second stage of ‘health transition'?Int. J. Epidemiol., 36, 384–386. Epub. 2007 Apr. 30.
61.
CoussyJ., and VallinJ. (1996) Crisis and demographic transition in Africa. Chron. CEPED., 1–5.
62.
TimaeusI.M. (1998) Impact of the HIV epidemic on mortality in sub-Saharan Africa: evidence from national surveys and censuses. AIDS, 12 Suppl 1, S15–27.
63.
KingG., and ZengL. (2001) Improving Forecasts of State Failure. World Politics, 53, 623–658.
64.
VictoraC.G., WagstaffA., SchellenbergJ.A., GwatkinD., ClaesonM., and HabichtJ.P. (2003) Applying an equity lens to child health and mortality: more of the same is not enough. lancet, 362, 233–241.
65.
MesléF. (2004) Mortality in Central and Eastern Europe: long-term trends and recent upturns. Demographic Research, accessed April 7th, 2007 at http://www.demographic-research.org 2, 46–70.
66.
OkolskiM. (1992) Anomalies in demographic transition in Poland. Geogr. Pol., 59, 41–53.
67.
TkatchenkoE., McKeeM., and TsourosA.D. (2000) Public health in Russia: the view from the inside. Health Policy Plan, 15, 164–169.
68.
TulchinskyT.H., and VaravikovaE.A. (1996) Addressing the epidemiologic transition in the former Soviet Union: strategies for health system and public health reform in Russia. Am. J. Public Health, 86, 313–320.
69.
ShkolnikovV., MesléF., and VallinJ. (1996) Health crisis in Russia. I. Recent trends in life expectancy and causes of death from 1970 to 1993. Popul., 8, 123–154.
70.
BoutayebA. (2006) The double burden of communicable and non-communicable diseases in developing countries. Trans. R. Soc. Trop. Med. Hyg., 100, 191–199.
71.
MurrayC.J.L., and LopezA.D. (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Published by the Harvard School of Public Health on behalf of the World Health Organization and the World Bank; Distributed by Harvard University Press, Cambridge, MA (USA).
72.
BoermaJ.T., and StansfieldS.K. (2007) Health statistics now: are we making the right investments?lancet, 369, 779–786.
73.
MathersC.D., FatD.M., InoueM., RaoC., and LopezA.D. (2005) Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull. World Health Organ., 83, 171–177.
74.
(2005) Stumbling around in the dark. lancet, 365, 1983.
75.
AbouZahrC., and VaughanJ.P. (2000) Assessing the burden of sexual and reproductive ill-health: questions regarding the use of disability-adjusted life years. Bull. World Health Organ., 78, 655–666.
76.
AnandS., and HansonK. (1997) Disability-adjusted life years: a critical review. J. Health Econ., 16, 685–702.
77.
MontD. (2007) Measuring health and disability. Lancet, 369, 1658–1663.
78.
BloomD.E., CanningD., and WestonM. (2005) The Value of Vaccination. World Economics, 6, 15–30.
79.
NiehausM.D., MooreS.R., PatrickP.D., DerrL.L., LorntzB., LimaA.A., and GuerrantR.L. (2002) Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. Am. J. Trop. Med. Hyg., 66, 590–593.
80.
DillinghamR., and GuerrantR.L. (2004) Childhood stunting: measuring and stemming the staggering costs of inadequate water and sanitation. Lancet, 363, 94–95.
81.
GuerrantD.I., MooreS.R., LimaA.A., PatrickP.D., SchorlingJ.B., and GuerrantR.L. (1999) Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. Am. J. Trop. Med. Hyg., 61, 707–713.
82.
EdmundsW., DejeneA., MekonnenY., HaileM., AlemnuW., and NokesD. (2000) The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa. Health Policy Plan, 15, 408–16.
83.
MiguelE., and KremerM. (2004) Worms: identifying impacts on education and health in the presence of treatment externalities. Econometrica, 72, 159–217.
84.
MendezM.A., and AdairL.S. (1999) Severity and timing of stunting in the first two years of life affect performance on cognitive tests in late childhood. J. Nutr., 129, 1555–1562.
85.
PritchettL., and SummersL.H. (1993) Wealthier is healthier (Office of the Vice President Development Economics World Bank, Washington, D.C.).
86.
BloomD.E., and CanningD. (2000) Policy forum: public health. The health and wealth of nations. Science, 287, 1207, 1209.
87.
BloomD.E., CanningD., and SevillaJ. (2004) The effect of health on economic growth: a production function approach. World Development, 32, 1–13.
SmithR.D. (2006) Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management. Soc. Sci. Med., 63, 3113–3123.
90.
BarretoM.L. (2003) Science, policy, politics, a complex and unequal world and the emerging of a new infectious disease. J. Epidemiol. Community Health, 57, 644–645.
91.
BlendonR.J., BensonJ.M., DesRochesC.M., RaleighE., and Taylor-ClarkK. (2004) The public's response to severe acute respiratory syndrome in Toronto and the United States. Clin. Infect. Dis., 38, 925–931.
92.
CalvinL. In: International Trade and Food Safety: Economic Theory and Case Studies, BusbyJ.C. (ed.) (2003) United States Department of Agriculture, Economic Research Service (AER-828).
93.
BeltonD.J. (2004) The macro-economic impact of a foot-and-mouth disease incursion in New Zealand. Dev Biol. (Basel), 119, 457–461.
94.
GarnerM.G., FisherB.S., and MurrayJ.G. (2002) Economic aspects of foot and mouth disease: perspectives of a free country, Australia. Rev. Sci. Tech., 21, 625–635.
95.
KrystynakR.H., and CharleboisP.A. (1987) The Potential Economic Impact of an Outbreak of Foot-and-Mouth Disease in Canada. Can. Vet. J., 28, 523–527.
96.
PaarlbergP.L., LeeJ.G., and SeitzingerA.H. (2002) Potential revenue impact of an outbreak of foot-and-mouth disease in the United States. J. Am. Vet. Med. Assoc., 220, 988–992.
97.
PerryB.D., GleesonL.J., KhounseyS., BounmaP., and BlacksellS.D. (2002) The dynamics and impact of foot and mouth disease in smallholder farming systems in South-East Asia: a case study in Laos. Rev. Sci. Tech., 21, 663–673.
98.
PerryB.D., KalpravidhW., ColemanP.G., HorstH.S., DermottJ.J., RandolphT.F., and GleesonL.J. (1999) The economic impact of foot and mouth disease and its control in South-East Asia: a preliminary assessment with special reference to Thailand. Rev. Sci. Tech., 18, 478–97.
99.
PerryB.D., and RichK.M. (2007) Poverty impacts of foot-and-mouth disease and the poverty reduction implications of its control. Vet. Rec., 160, 238–241.
100.
RandolphT.F., PerryB.D., BenignoC.C., SantosI.J., AgbayaniA.L., ColemanP., WebbR., and GleesonL.J. (2002) The economic impact of foot and mouth disease control and eradication in the Philippines. Rev. Sci. Tech., 21, 645–661.
101.
HallC. (2004) Impact of avian influenza on U.S. poultry trade relations-2002: H5 or H7 low pathogenic avian influenza. Ann. N.Y. Acad. Sci., 1026, 47–53.
102.
Spread of Avian Flu Could Affect Next Year's Economic Outlook. In: The World Bank. East Asia Update–Countering Global Shocks, accessed June 9, 2007 from http://www.worldbank.org/eapupdate.
103.
BramhmbhattM. (2006) Economic Impacts of Avian Influenza Propagation, In: First International Conference on Avian Influenza in Humans, June 29, 2006; Paris, France.
104.
(2006) Economic and social impact of epidemic and pandemic influenza. Vaccine, 24, 6776–6778.
105.
International Monetary Fund. Avian Flu Working Group.The global economic and financial impact of an avian flu pandemic and the role of the IMF (International Monetary Fund, Washington, D.C., 2006).
106.
BrundtlandG.H.Health brings wealth, in BBC News Online: Business, Friday, 23 March, 2001:BBC, London.
107.
FolchE., HernandezI., BarraganM., and Franco-ParedesC. (2003) Infectious diseases, non-zero-sum thinking, and the developing world. Am. J. Med. Sci., 326, 66–72.
108.
United Nations Millennium Declaration Resolution 55/2 adopted by the General Assembly in Millennium Summit.2000. accessed from http://www.u-n.org/millennium/ on June 9, 2007.
109.
ShiftmanJ. (2006) Donor funding priorities for communicable disease control in the developing world. Health Policy Plan, 21, 411–420.
110.
WagstaffA. (2001) Economics, health and development: some ethical dilemmas facing the World Bank and the international community. J. Med. Ethics, 27, 262–267.
111.
(2007) Millennium development holes. Nature, 446, 347.
112.
BloomD.E. (2006) Education in a globalized world. World Economics, 1, 87–109.
113.
HawkesC., and RuelM. (2006) The links between agriculture and health: an intersectoral opportunity to improve the health and livelihoods of the poor. Bull. World Health Organ., 84, 984–990.
114.
World Bank (1998) Assessing aid: what works, what doesn't, and why Assessing aid. World Bank policy research report. Washington, D.C.: Oxford University Press. xii, 148.
115.
WagstaffA., ClaesonM. and World Bank. (2004) The millennium development goals for health: rising to the challenges.Washington, DC: World Bank. xv, 186.
116.
LewisM. (2006) Governance and Corruption in Public Health Care Systems. Working Paper Number 78.Center for Global Development (www.cgdev.org).
117.
GayleH.D., and HillG.L. (2001) Global impact of human immunodeficiency virus and AIDS. Clin. Microbiol. Rev., 14, 327–335.
SteinbrookR. (2007). HIV in India–a complex epidemic. N. Engl. J. Med., 356, 1089–1093.
120.
BertozziS., PadianN.S., WegbreitJ., DeMariaL.M., FeldmanB., GayleH., GoldJ., GrantR., and IsbellM.T. (2006) HIV/AIDS prevention and treatment in Disease Control Priorities in Developing Countries.JamisonD. T. (ed.), Oxford University Press, New York, NY.
121.
NicollA., and GillO.N. (1999) The global impact of HIV infection and disease. Commun. Dis. Public Health, 2, 85–95.
122.
UNAIDS (2006) Report on the Global AIDS Epidemic.Geneva, Switzerland, 1999.
123.
YeniP.G., HammerS.M., HirschM.S., SaagM.S., SchechterM., CarpenterC.C., FischlM.A., GatellJ.M., GazzardB.G., JacobsenD.M., KatzensteinD.A., MontanerJ.S., RichmanD.D., SchooleyR.T., ThompsonM.A., VellaS., and VolberdingP.A. (2004). Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA, 292, 251–265.
CorbettE.L., WattC.J., WalkerN., MaherD., WilliamsB.G., RaviglioneM.C., and DyeC. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med., 163, 1009–1021.
128.
KhatriG.R., and FriedenT.R. (2002) Controlling tuberculosis in India. N. Engl. J. Med., 347, 1420–1425.
129.
OkekeI.N., LaxminarayanR., BhuttaZ.A., DuseA.G., JenkinsP., O'BrienT.F., Pablos-MendezA., and KlugmanK.P. (2005) Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect. Dis., 5, 481–493.
KosekM., BernC., and GuerrantR.L. (2003) The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull. World Health Organ., 81, 197–204.
134.
ChengA.C., McDonaldJ.R., and ThielmanN.M. (2005) Infectious diarrhea in developed and developing countries. J. Clin. Gastroenterol., 39, 757–773.
135.
GiaquintoC., Van DammeP., HuetF., GotheforsL., MaxwellM., ToddP., and da DaltL. (2007) Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004–2005: the REVEAL study. J. Infect. Dis., 195 Suppl 1, S26–S35.
BrenzelL., WolfsonL.J., Fox-RushbyJ., MillerM., and HalseyN.A. (2006) Vaccine Preventable Diseases. In: In Disease Control Priorities in Developing Countries, JamisonD. T. (ed.), Oxford University Press, New York, NY, 2006.
139.
RobertsL. (2004) Polio endgame. The exit strategy. Science, 303, 1969–1971.
140.
WHO (2001) Global prevalence and incidence of selected curable sexually transmitted infections: Overview and estimates. Accessed on May 28, 2006 at http://www.who.int/hiv/pub/sti/pub7/en/.
141.
WasserheitJ.N., and AralS.O. (1996) The dynamic topology of sexually transmitted disease epidemics: implications for prevention strategies. J. Infect. Dis., 17A Suppl 2, S201–S213.
142.
LagaM., NzilaN., and GoemanJ. (1991) The interrelationship of sexually transmitted diseases and HIV infection: implications for the control of both epidemics in Africa. Aids, 5, S55–S63.
143.
StephensonL.S., LathamM.C., and OttesenE.A. (2000) Malnutrition and parasitic helminth infections. Parasitology, 121, S23–S38.
144.
EngelsD., and SavioliL. (2006) Reconsidering the underestimated burden caused by neglected tropical diseases. Trends Parasitol., 22, 363–366. Epub. 2006 Jun 23.
145.
GublerD.J. (2006) Dengue/dengue haemorrhagic fever: history and current status. Novartis Found Symp., 211, 3–16.
146.
Wilder-SmithA., and SchwartzE. (2005) Dengue in travelers. N. Engl. J. Med., 353, 924–932.
147.
IsturizR.E., GublerD.J., and Brea del CastilloJ. (2000) Dengue and dengue hemorrhagic fever in Latin America and the Caribbean. Lnfect. Dis. Clin. North Am., 14, 121–140, ix.
148.
MelinoS., and PaciM. (2007) Progress for dengue virus diseases. Febs. J., 274, 2986–3002. Epub. 2007 May 17.
MurrayH.W., BermanJ.D., DaviesC.R., and SaraviaN.G. (2005). Advances in leishmaniasis. Lancet, 366, 1561–1577.
151.
PepinJ., and MedaH.A. (2001) The epidemiology and control of human African trypanosomiasis. Adv. Parasitol., 49, 71–132.
152.
SmithD.H., PepinJ., and StichA.H. (1998) Human African trypanosomiasis: an emerging public health crisis. Br. Med. Bull., 54, 341–355.
153.
MurrayC.J., LopezA.D., ChinB., FeehanD., and HillK.H. (2006) Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysis. Lancet, 368, 2211–2218.
154.
ChretienJ.P., BlazesD.L., GaydosJ.C., BednoS.A., ColdrenR.L., CulpepperR.C., FyrauffD.J., EarhartK.C., MansourM.M., GlassJ.S., LewisM.D., SmoakB.L., and MaloneJ.L. (2006) Experience of a global laboratory network in responding to infectious disease epidemics. Lancet Infect. Dis., 6, 538–540.
155.
ChretienJ.P., GaydosJ.C., MaloneJ.L., and BlazesD.L. (2006) Global network could avert pandemics. Nature, 440, 25–26.
156.
CashR.A., and NarasimhanV. (2000) Impediments to global surveillance of infectious diseases: consequences of open reporting in a global economy. Bull. World Health Organ., 78, 1358–1367.
157.
BreseeJ., FangZ.Y., WangB., NelsonE.A., TarnJ., SoenartoY., WilopoS.A., KilgoreP., KimJ.S., KangJ.O., LanW.S., GaikC.L., MoeK., ChenK.T., JiraphongsaC., PonguswannaY., NguyenV.M., PhanV.T., LeT.L., HummelmanE., GentschJ.R., and GlassR. (2004) First report from the Asian Rotavirus Surveillance Network. Emerg. Infect. Dis., 10, 988–95.
